Update: The FDA Unanimously Recommends Approval of the First CAR-T Therapy
Update (08/08/2017): The FDA has cleared Kite Pharma, Novartis' main competitor to launch the first…
08/08/2017 - 3 minutes
CAR-T
American CAR-T Leader Eyes Europe, Initiating Market Approval Process & Clinical Trial
Kite is charging ahead in Europe with a clinical trial and marketing authorization application as…
08/08/2017 - 2 minutes
Celyad Starts a Third CAR-T Trial, in Metastatic Colorectal Cancer
Celyad has started the SHRINK trial, which will evaluate the synergistic effects of the company's…
20/07/2017 - 1 minute
Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns
Editor's Note: Novartis did note a death from cerebral hemorrhage in its hearing with the…
11/07/2017 - 3 minutes
Cutting Through the BS in Biopharma: How To Spot Hype
Faced with the oft-quoted figure that 90% of clinical trials end in failure, how can…
05/07/2017 - 4 minutes
Servier Recruits Viral Vector Expert to Step Up its CAR-T Technology
Transgene will help Servier develop new methods based on viral vectors to improve the precision…
29/06/2017 - 2 minutes
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic
Update (28/06/2017): Cellectis has announced the first administration of UCART123 in its Phase I trial…
28/06/2017 - 3 minutes
New Results from Novartis in the Race to Launch the First CAR-T
Novartis has announced an update on the performance of CTL019, a CAR-T therapy against leukemia…
26/06/2017 - 2 minutes
British Biotech Tops up its Cancer Pipeline with New TCR Therapy
Cell Medica just acquired Catapult Therapy TCR, set up by UK's CGT Catapult, gaining the…
21/06/2017 - 2 minutes
Celyad Reports Impressive Preliminary CAR-T Results in Solid Tumors
Celyad has announced no toxicity and stable disease in colorectal cancer patients after just 3…
19/06/2017 - 2 minutes
New Public-Private French Collaboration will Develop CAR-Tregs
TxCell has partnered with Inserm and the Nantes University to develop a new class of…
03/05/2017 - 1 minute
Novartis Gains Access to Celyad’s allogenic CAR-T cell patents
Belgian Celyad is giving Novartis access to its IP for the production of allogeneic CAR-T…
02/05/2017 - 2 minutes
